Antimalarial drug resistance in Bangladesh, 1996-2012

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 107, Issue 12, 2013, Pages 745-752

  Haque, Ubydul ^a   Glass, Gregory E ^a   Haque, Waziul ^b   Islam, Nazrul ^c   Roy, Shyamal ^c   Karim, Jahirul ^c   Noedl, Harald ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b OSLO METROPOLITAN UNIVERSITY   (Norway)

^c MINISTRY OF HEALTH AND FAMILY WELFARE   (Bangladesh)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bangladesh; Drug; Malaria; Resistance

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; AZITHROMYCIN; CHLOROQUINE; CLINDAMYCIN; DOXYCYCLINE; MEFLOQUINE; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; QUININE SULFATE; TETRACYCLINE; ANTIMALARIAL AGENT;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BANGLADESH; DISEASE SEVERITY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MONOTHERAPY; NONHUMAN; DRUG EFFECTS; DRUG RESISTANCE; EPIDEMIOLOGY; MALARIA, FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

ANTIMALARIALS; BANGLADESH; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

EID: 84887969582     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trt088     Document Type: Article

References (42)

1. Reid H, Haque U, Roy S et al. Characterizing the spatial and temporal variation of malaria incidence in Bangladesh, 2007. Malar J 2012;11:170.
2. Global Fund to Fight AIDS, Tuberculosis and Malaria. http://portfolio. theglobalfund.org/en/Country/Index/BGD. [accessed 11 September 2013].
3. Haque U, Ahmed SM, Hossain S et al. Malaria prevalence in endemic districts of Bangladesh. PLoS One 2009;4:e6737.
4. Rahman W, Chotivanich K, Silamut K et al. Plasmodium malariae in Bangladesh. Trans R Soc Trop Med Hyg 2010;104:78-80.
5. Fuehrer HP, Starzengruber P, Swoboda P et al. Indigenous Plasmodium ovale malaria in Bangladesh. Am J Trop Med Hyg 2010;83:75-8.
6. Haque U, Hashizume M, Glass GE et al. The role of climate variability in the spread of malaria in Bangladeshi highlands. PLoS One 2010;5:e14341.
7. National Malaria Control Program, Bangladesh. Database site of NMCP. Available at:www.nmcp.gov.bd. [accessed 11 September 2013].
8. Global Fund to Fight AIDS, Tuberculosis and Malaria. http://portfolio. theglobalfund.org/en/Country/Index/BGD. [accessed 11 September 2013].
9. Alam P. Malaria country report:Bangladesh. Dhaka, Bangladesh: Directorate General of Health Services, Malaria and Parasitic Disease Control Unit; 2008.
10. Rosenberg R, Maheswary NP. Chloroquine resistant Plasmodium falciparum in Bangladesh. Trans R Soc Trop Med Hyg 1976;70:533.
11. White NJ, PongtavornpinyoW, Maude RJ et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J 2009;8.
12. WHO. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000;94 Suppl 1:S1-90.
13. National Malaria Control Program, Bangladesh. Revised malaria treatment regimen 2009. Dhaka, Bangladesh:Directorate General of Health Services, Ministry of Health and Family Welfare, 2009.
14. Kawai A, Arita N, Matsumoto Y et al. Efficacy of chloroquine plus primaquine treatment and pfcrt mutation in uncomplicated falciparum malaria patients in Rangamati, Bangladesh. Parasitol Int 2011;60:341-6.
15. Thriemer K, Starzengruber P, KhanWA et al. Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh:an open-label randomized, controlled clinical trial. J Infect Dis 2010;202:392-8.
16. Haque R, Thriemer K, Wang Z et al. Therapeutic efficacy of artemether- lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh. Am J Trop Med Hyg 2007;76:39-41.
17. WHO. Guidelines for the treatment of malaria, 2nd edn. Geneva:WHO; 2010.
18. Taylor-Robinson D, Jones K, Garner P. Malaria:uncomplicated, caused by Plasmodium falciparum. Clin Evid (Online) 2007 Oct 1;2007. pii:0919.
19. ClinicalTrials.gov. Antimalarial drug resistance in Mali. Available at: http://www.clinicaltrials.gov/[accessed 11 September 2013].
20. Starzengruber P, Swoboda P, Fuehrer HP et al. Current status of artemisinin-resistant falciparum malaria in South Asia:a randomized controlled artesunate monotherapy trial in Bangladesh. PLoS One 2012;7:e52236.
21. Rahman MM, Dondorp AM, Day NP et al. Adherence and efficacy of supervised versus non-supervised treatment with artemether/ lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh:a randomised controlled trial. Trans R Soc Trop Med Hyg 2008;102:861-7.
22. van den Broek IV, Maung UA, Peters A et al. Efficacy of chloroquine+sulfadoxine-pyrimethamine, mefloquine+artesunate and artemether+lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. Trans R Soc Trop Med Hyg 2005;99:727-35.
23. Rahman MR, Paul DC, Rashid M et al. A randomized controlled trial on the efficacy of alternative treatment regimens for uncomplicated falciparum malaria in a multidrug-resistant falciparum area of Bangladesh-narrowing the options for the National Malaria Control Programme? Trans R Soc Trop Med Hyg 2001;95:661-7.
24. Thriemer K, Haque R, Wagatsuma Y et al. Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh. Am J Trop Med Hyg 2006;75:645-9.
25. van den Broek IV, van der Wardt S, Talukder L et al. Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh. Trop Med Int Health 2004;9:680-7.
26. Rahman MR, Hassan MR, Faiz MA et al. Monitoring efficacy of commonly used antimalarials by a 14-day in-vivo test in a new settler's camp in endemic zone at Cox's Bazar. Bangladesh Med Res Council Bull 1998;24:67-74.
27. Rahman M, Rahman R, Bangali M et al. Efficacy of combined chloroquine and sulfadoxine-pyrimethamine in uncomplicated Plasmodium falciparum malaria in Bangladesh. Trans R Soc Trop Med Hyg 2004;98:438-41.
28. Dondorp A, Nosten F, Stepniewska K et al. Artesunate versus quinine for treatment of severe falciparum malaria:a randomised trial. Lancet 2005;366:717-25.
29. Faiz MA, Rahman E, Hossain MA et al. A randomized controlled trial comparing artemether and quinine in the treatment of cerebral malaria in Bangladesh. Indian J Malariol 2001;38:9-18.
30. Gomes MF, Faiz MA, Gyapong JO et al. Pre-referral rectal artesunate to prevent death and disability in severe malaria:a placebo-controlled trial. Lancet 2009;373:557-66.
31. Thriemer K, Khan WA, Starzengruber P et al. In vitro interaction of dihydroartemisin and lumefantrine in clinical field isolates from Bangladesh. Wien Klin Wochenschr 2007;119 Suppl 3:67-70.
32. Boni MF, Smith DL, Laxminarayan R. Benefits of using multiple first-line therapies against malaria. Proc Natl Acad Sci U S A 2008;105:14216-27.
33. Haque U, Scott LM, Hashizume M et al. Modelling malaria treatment practices in Bangladesh using spatial statistics. Malar J 2012;11.
34. Mbonye AK, Ndyomugyenyi R, Turinde A et al. The feasibility of introducing rapid diagnostic tests for malaria in drug shops in Uganda. Malar J 2010;9:367.
35. Swoboda P, Starzengruber P, Fuehrer H et al. Comprehensive epidemiological research effort on febrile illness and hemoglobinopathies along the Bangladesh-Myanmar border. American Society of Tropical Medicine and Hygiene 4-8 December 2011; Philadelphia:Pennsylvania.
36. Haque U, Hashizume M, Sunahara T et al. Progress and challenges to control of malaria in a remote area of Chittagong hill tracts, Bangladesh. Malar J 2010;9:156.
37. Yang Z, Li C, Miao M. et al. Multidrug-resistant genotypes of Plasmodium falciparum, Myanmar. Emerg Infect Dis 2011;17:498-501.
38. Marma AS, Mita T, Eto H et al. High prevalence of sulfadoxine/ pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh. Parasitol Int 2010;59:178-82.
39. Noedl H, Se Y, Schaecher K et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008;359:2619-20.
40. Noedl H, Socheat D, Satimai W. Artemisinin-resistant malaria in Asia. N Engl J Med 2009;361:540-1.
41. Muller O, Sie A, Meissner P et al. Artemisinin resistance on the Thai-Cambodian border. Lancet 2009;374:1419.
42. Phyo AP, Nkhoma S, Stepniewska K et al. Emergence of artemisininresistant malaria on the western border of Thailand:a longitudinal study. Lancet 2012;379:1960-6.